| Name | Last modified | Size | Description | |
|---|---|---|---|---|
| Parent Directory | - | |||
| sem-5-antihistaminic..> | 2023-05-22 04:09 | 338K | ||
| prodrugs.pdf | 2023-05-22 04:36 | 370K | ||
| probility-distributi..> | 2023-05-22 04:50 | 310K | ||
| pharmaceutical-aeros..> | 2023-05-22 04:36 | 1.5M | ||
| liquid-orals-T-Y-Pha..> | 2023-05-22 05:56 | 7.4M | ||
| introduction-to-rati..> | 2023-05-22 05:46 | 727K | ||
| electro-physiology-o..> | 2023-05-22 05:46 | 3.1M | ||
| ch.-3-Drug-Distribut..> | 2023-05-22 04:50 | 1.9M | ||
| carbohydrates_818803..> | 2023-05-22 05:34 | 1.1M | ||
| WHO_Guideline_for_Qu..> | 2023-05-22 05:30 | 823K | ||
| Types-of-dosage-form..> | 2023-05-22 05:34 | 380K | ||
| Tissues.pdf | 2023-05-22 05:34 | 1.9M | ||
| TabletCoating-T-Y-Ph..> | 2023-05-22 05:56 | 1.8M | ||
| Tablet-T-Y-PharmD.pdf | 2023-05-22 05:56 | 2.3M | ||
| TYPD-paperchromatogr..> | 2023-05-22 05:56 | 1.5M | ||
| TYPD-notes-validatio..> | 2023-05-22 05:56 | 663K | ||
| TYPD-flourimeter.pdf | 2023-05-22 05:56 | 2.5M | ||
| Suppositories-F-Y-Ph..> | 2023-05-22 05:34 | 1.9M | ||
| Sterility-testing-S-..> | 2023-05-22 05:46 | 1.4M | ||
| SCHEDULE_-_T_Dr._Kau..> | 2023-05-22 05:30 | 13M | ||
| Regression-and-corre..> | 2023-05-22 04:54 | 418K | ||
| QSAR.pdf | 2023-05-22 04:36 | 1.1M | ||
| Plasma-Protein-bindi..> | 2023-05-22 04:36 | 1.2M | ||
| Plant-based-Ind-Inst..> | 2023-05-22 04:36 | 451K | ||
| Phenols.pdf | 2023-05-22 05:34 | 1.4M | ||
| Pharmacy-Act-1948.pdf | 2023-05-22 05:56 | 267K | ||
| PROTEIN-CALORIE-MALN..> | 2023-05-22 05:46 | 1.0M | ||
| PREFORMULATION.pdf | 2023-05-22 04:36 | 337K | ||
| PATIENT-MEDICATION-A..> | 2023-05-22 05:46 | 577K | ||
| OPHTHALMIC-PRODUCTS.pdf | 2023-05-22 04:36 | 1.1M | ||
| Nucleic-Acids-DNA-RN..> | 2023-05-22 05:34 | 2.4M | ||
| Natural-Excipiernts-..> | 2023-05-22 04:35 | 447K | ||
| NIOSOME-Digital-Note..> | 2023-05-22 04:50 | 329K | ||
| NAME-REACTIONS.pdf | 2023-05-22 05:34 | 389K | ||
| Medical-Toilet-Prepa..> | 2023-05-22 05:56 | 754K | ||
| Measures-of-Dispersi..> | 2023-05-22 04:50 | 213K | ||
| Macrolide-Antibiotic..> | 2023-05-22 05:56 | 271K | ||
| MODES-OF-MOLECULAR-V..> | 2023-05-22 05:07 | 624K | ||
| MEDICINAL-CHEMISTRY-..> | 2023-05-22 04:36 | 338K | ||
| MEDICINAL-CHEMISTRY-..> | 2023-05-22 03:53 | 681K | ||
| LIQUID-DOSAGE-FORMS_..> | 2023-05-22 05:34 | 6.5M | ||
| ION-EXCHANGE-CHROMAT..> | 2023-05-22 04:50 | 528K | ||
| INFLAMMATION.pdf | 2023-05-22 05:46 | 2.2M | ||
| Human-Respiratory-Sy..> | 2023-05-22 05:34 | 486K | ||
| H2-Antagonist.pdf | 2023-05-22 03:53 | 344K | ||
| Guidelines-for-the-u..> | 2023-05-22 05:56 | 392K | ||
| GMP_for_herbal_medic..> | 2023-05-22 05:30 | 1.0M | ||
| GMP-for-ASU-medicine..> | 2023-05-22 04:36 | 349K | ||
| GLUCOMA-FINAL.pdf | 2023-05-22 05:46 | 2.9M | ||
| FYPD-notes-antacids-..> | 2023-05-22 05:34 | 857K | ||
| FYPD-non-aqueous-tit..> | 2023-05-22 05:34 | 685K | ||
| FYPD-Introduction-to..> | 2023-05-22 05:35 | 879K | ||
| FLAME-PHOTOMETRY_BP7..> | 2023-05-22 04:50 | 654K | ||
| FLAME-PHOTOMETRY_BP7..> | 2023-05-22 04:50 | 654K | ||
| Evaluation-of-Disinf..> | 2023-05-22 05:46 | 1.1M | ||
| Drugs-Used-in-Treatm..> | 2023-05-22 05:46 | 640K | ||
| DrugDissolution_BP60..> | 2023-05-22 04:36 | 1.3M | ||
| Digital-Note-_GASTRO..> | 2023-05-22 04:36 | 135K | ||
| Digital-Note-Content..> | 2023-05-22 05:30 | 287K | ||
| D-_-C-Act.pdf | 2023-05-22 05:56 | 960K | ||
| Cycloalkanes.pdf | 2023-05-22 05:34 | 1.7M | ||
| Code-of-ethics.pdf | 2023-05-22 05:46 | 85K | ||
| Classification-of-Ba..> | 2023-05-22 05:46 | 1.5M | ||
| Ch.3-Gastroentritis.pdf | 2023-05-22 05:56 | 1.1M | ||
| Ch.1-Hospital-organi..> | 2023-05-22 04:50 | 769K | ||
| Cell-2.pdf | 2023-05-22 05:34 | 1.2M | ||
| CH.3-ADR-CAUSALITY-A..> | 2023-05-22 04:50 | 829K | ||
| CANCER-PATHOLOG.pdf | 2023-05-22 05:46 | 1.6M | ||
| BP7-notes-GLP-for-QC..> | 2023-05-22 04:50 | 360K | ||
| BP7-notes-GLP-for-QC..> | 2023-05-22 04:50 | 360K | ||
| BP7-QC-CONTATINER-CL..> | 2023-05-22 04:50 | 1.4M | ||
| Avalokan-5.pdf | 2023-05-22 04:54 | 624K | ||
| Antiscabious-and-Ant..> | 2023-05-22 05:56 | 155K | ||
| Anti-hypertensive-Dr..> | 2023-05-22 05:46 | 552K | ||
| Anti-Viral-Drugs.pdf | 2023-05-22 05:56 | 1.1M | ||
| Anti-Fungal-Agents.pdf | 2023-05-22 05:57 | 363K | ||
| Anti-Anginal-Agents.pdf | 2023-05-22 05:46 | 1.0M | ||
| Aminoglycosides-a.pdf | 2023-05-22 05:04 | 567K | ||
| Aminoglycosides-Anti..> | 2023-05-22 05:00 | 567K | ||
| ASTHMA.pdf | 2023-05-22 05:47 | 1.4M | ||
| ANTIVIRAL-AGENTS-dig..> | 2023-05-22 05:56 | 251K | ||
| AMINOGLYCOSIDE-ANTIB..> | 2023-05-22 05:57 | 658K | ||
| 8.Pulmonary-Drug-del..> | 2023-05-22 04:50 | 2.8M | ||
| 7-Factor-affecting-c..> | 2023-05-22 05:46 | 1.2M | ||
| 6.TRANSDERMAL-DDS-DJ..> | 2023-05-22 04:50 | 3.5M | ||
| 3-classification-of-..> | 2023-05-22 05:46 | 1.0M | ||
| 2.-Drug-Registration..> | 2023-05-22 05:30 | 436K | ||
| 1.MHRA_.pdf | 2023-05-22 05:30 | 1.1M | ||
| 1-introduction-of-ph..> | 2023-05-22 05:46 | 854K | ||